Concurrent engineering in a pharmaceutical firm: a case study of Dr Reddy's Laboratories Ltd

G.V. Prasad and B. Madhusudan Rao

International Journal of Manufacturing Technology and Management, 2004, vol. 6, issue 3/4, 280-290

Abstract: Dr Reddy's Laboratories is a successful pharmaceutical firm in India. It has developed a number of new chemical entities and some of them are undergoing clinical trials. Dr Reddy's also develops generics for export. Reducing the development cycle time has become one of the critical success factors in the pharmaceutical industry. This case study illustrates the demonstration of cycle time reduction through the use of overlapping phases of development, using a cohesive cross functional team effort, supported by a series of performance matrices.

Keywords: bulk actives; critical to process parameters; critical to quality parameters; cross functional team; cycle time reduction; drug master file; generic drug; intellectual property; polymorph; safety; health; environment; technology transfer; USFDA; validation; pharmaceutical industry; India; concurrent engineering; simultaneous engineering. (search for similar items in EconPapers)
Date: 2004
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.inderscience.com/link.php?id=5405 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ids:ijmtma:v:6:y:2004:i:3/4:p:280-290

Access Statistics for this article

More articles in International Journal of Manufacturing Technology and Management from Inderscience Enterprises Ltd
Bibliographic data for series maintained by Sarah Parker ().